Alistair Lj Symonds

5PUBLICATIONS
13CO-AUTHORS
Innate immunityCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursTumour immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 21, 2024
Memory Phenotype Tfh Cells Develop Without Overt Infection and Support Germinal Center Formation and B Cell Responses to Viral Infection.

Alistair L J Symonds, Zabreen Busharat, Mengmeng Du

|Jan 18, 2023
CD200+ cytotoxic T lymphocytes in the tumor microenvironment are crucial for efficacious anti-PD-1/PD-L1 therapy.

Xinxin Wang, Haoran Zha, Wei Wu

|Nov 07, 2022
Egr2 and 3 maintain anti-tumour responses of exhausted tumour infiltrating CD8 + T cells.

Alistair L J Symonds, Tizong Miao, Zabreen Busharat

|Jul 26, 2020
Egr2 and 3 control inflammation, but maintain homeostasis, of PD-1high memory phenotype CD4 T cells.

Alistair Lj Symonds, Wei Zheng, Tizong Miao

|Jan 10, 2018
Transcription factors early growth response gene (Egr) 2 and 3 control inflammatory responses of tolerant T cells.

Becky Omodho, Tizong Miao, Alistair L J Symonds

Pageof 1

Frequent Collaborators

2 joint publications

Suling Li

2 joint publications

Ping Wang

1 joint publications

Xinxin Wang

1 joint publications

Haoran Zha